ACCEL Lite: ESC Late Breaker: MASTER DAPT

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Content provided by American College of Cardiology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American College of Cardiology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

3y ago 12:05

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on June 01, 2023 17:14 (1+ y ago). Last successful fetch was on April 25, 2023 16:40 (1+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

This large, multicentre, randomized trial was conducted with patients at high risk for bleeding who had undergone biodegradable polymer sirolimus-eluting stent implantation to assess whether one month of dual antiplatelet therapy preserves the net and major adverse cardiovascular events. And if so, whether it mitigates major or nonmajor clinically relevant bleeding occurrences, compared with longer treatment durations.

In this episode, Prof Marco Valgimigli, MD, PhD, FESC and Poonam Velagapudi MD, MS discuss ESC Late Breaker: MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients.

Like what you hear? Get 20 episodes/month with CME/MOC credit! www.acc.org/ACCEL

101 episodes

#Fitness #Cardiology #Science #Medicine #Podcasting Education #American College Of Cardiology #Heart Failure